[European ethics committees in transition: challenges of new requirements].

Europäische Ethikkommissionen im Wandel: Herausforderungen durch neue Rahmenbedingungen.
Ethical counseling Ethos European harmonisation Good scientific practice Research ethics

Journal

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz
ISSN: 1437-1588
Titre abrégé: Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz
Pays: Germany
ID NLM: 101181368

Informations de publication

Date de publication:
Jun 2019
Historique:
pubmed: 10 5 2019
medline: 19 9 2019
entrez: 10 5 2019
Statut: ppublish

Résumé

Guided by the example of ethics committees in medicine, the ethical review system of research projects in Europe is increasingly expanding to other disciplines such as psychology, the social sciences, and engineering, especially when human subjects are directly involved or personal data are collected. However, ethical reviews are not uniformly regulated in most European countries.With the new EU Regulation No. 536/2014, which is expected to come into force in 2020, it is intended to standardize the work of medical research ethics committees for clinical trials. Clear deadlines and the use of a central electronic EU portal are also given in order to accelerate the approval process for economic reasons. Member states are left free in terms of the scope of the ethical review, but this would run counter to unification and could lead some to choose a test model that excludes the evaluation of the methodology and risks of a study and thus contributes less to the protection of the participants.The European Research Ethics Committees have been working together since 2005 within the European Network of Research Ethics Committees (EUREC). For a discussion on the impact and implementation of the new EU Regulation and on the development of the EU portal, EUREC has provided a forum for a qualified debate.In this period of change, it is not clear yet which direction the ethics committees will develop. Professional management can have a positive impact on the quality of the ethics review. However, the marginalization inherent in the EU Regulation is counteracting the increasing evaluation of nonmedical research projects and adequate protection of subjects.

Identifiants

pubmed: 31069417
doi: 10.1007/s00103-019-02952-8
pii: 10.1007/s00103-019-02952-8
doi:

Types de publication

Journal Article Review

Langues

ger

Sous-ensembles de citation

IM

Pagination

697-705

Auteurs

Dirk Lanzerath (D)

Deutsches Referenzzentrum für Ethik in den Biowissenschaften (DRZE), Universität Bonn, Bonner Talweg 57, 53113, Bonn, Deutschland. lanzerath@drze.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH